Sherman Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143K Sell
1,116
-592
-35% -$69.3K 0.11% 64
2026
Q1
$205K Hold
1,708
– – 0.19% 47
2025
Q4
$180K Hold
1,708
– – 0.15% 63
2025
Q3
$143K Sell
1,708
-256
-13% -$21.1K 0.12% 66
2025
Q2
$156K Sell
1,964
-1
-0.1% -$79 0.14% 64
2025
Q1
$176K Sell
1,965
-9
-0.5% -$840 0.17% 61
2024
Q4
$196K Buy
+1,974
New +$204K 0.18% 58

Other funds holding MRK

Sherman Asset Management's MRK Position: Q2 2026 in Review

Sherman Asset Management reduced its Merck (MRK) stake by 35% in Q2 2026, selling an estimated $69.3K and leaving 1,116 shares worth $143K. The position accounts for 0.11% of the portfolio, ranked #64.

Sherman Asset Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $205K in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sherman Asset Management held 1,116 shares of Merck worth $143K as of Q2 2026.
  • Sherman Asset Management sold 592 Merck shares in Q2 2026, an estimated $69.3K.
  • Merck made up 0.11% of Sherman Asset Management's portfolio in Q2 2026, its #64 holding.
  • Sherman Asset Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Sherman Asset Management's Merck position peaked at $205K in Q1 2026.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sherman Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.